Today: 19 May 2026
Samsung Electro-Mechanics stock in focus after report links it to Nvidia’s AI chip supply chain
1 February 2026
1 min read

Samsung Electro-Mechanics stock in focus after report links it to Nvidia’s AI chip supply chain

Seoul, February 1, 2026, 10:50 KST — The market has closed.

  • Shares ended Friday at 279,000 won, slipping 0.18%.
  • The weekend report pointed to a potential AI-chip substrate supply deal linked to Nvidia.
  • Monday’s open will reveal if investors jump on the AI supply-chain theme or pull back from it.

When South Korean markets open Monday, all eyes will be on Samsung Electro-Mechanics after reports over the weekend revealed the company has become part of Nvidia’s AI chip supply chain. The stock closed Friday at 279,000 won.

The timing is crucial as investors pile into Asia’s AI supply-chain stocks, with substrates ranking among the tightest bottlenecks. A solid “new customer” signal can swiftly revalue a components maker, often ahead of any volume impact on earnings.

It arrives on a quiet news weekend. Without any trading sessions to immediately process it, investors have two days to reassess the implications—and decide if it shifts the 2026 profit outlook.

South Korea’s Seoul Economic Daily reported Saturday that Samsung Electro-Mechanics has entered “Company N’s” FC-BGA supply chain for AI semiconductors, breaking into a market long held by Japanese firms like Shinko Electric Industries and Ibiden. FC-BGA, or flip-chip ball grid array, is a high-end package substrate sitting beneath advanced chips to link them to the broader system. The report also mentioned NVSwitch, a hardware interconnect used in multi-GPU server racks. Seoul Economic Daily

Shares slipped 0.18% on Friday, ending a volatile week that kept the stock close to its recent peak. Friday’s trading volume came in around 711,000 shares.

Chip-related stocks are feeling mounting pressure. Last week, Samsung Electronics highlighted a deepening memory-chip shortage fueled by AI demand, cautioning that higher chip prices might squeeze its smartphone and display units. The stock slipped 1.2% following the earnings release. “Memory price increases are expected to accelerate this quarter,” Sohn In-joon of Heungkuk Securities noted in a report. Reuters

Samsung Electro-Mechanics’ upside rests on shifting its product mix: boosting AI-server substrates and premium capacitors while cutting back on low-margin commodity sales. Investors will be looking closely to see if any “new customer” buzz signals ongoing utilization or merely a brief test run.

There’s risk here. Supply-chain gains might show up but still fall short on the earnings sheet: volume growth could be sluggish, pricing might weaken, and top-tier substrate projects could stall if GPU server demand falters or clients shift their designs. Plus, even a robust AI cycle risks dragging down other segments if smartphone sales cool off.

Monday’s playbook is clear-cut. Traders will be scanning for any confirmation, denial, or disclosure from the company, the customer, or the Korea Exchange. After that, attention will shift to how the stock performs relative to the broader Korean chip sector.

The next obvious catalyst comes when markets reopen Monday, February 2. The key question: will the report spark lasting buying, or will enthusiasm fade as investors separate confirmed facts from speculation?

Stock Market Today

  • Q1 Earnings Review: Knowles Outshines Peers in Electronic Components Sector
    May 19, 2026, 6:20 AM EDT. Electronic components & manufacturing sector posted strong Q1 results, with revenues beating analysts' consensus by 3.8% and share prices rising 11% on average. Knowles (NYSE:KN) led within the group, reporting $153.1 million in revenues, up 15.8% year-on-year, surpassing expectations by 3.9%. CEO Jeffrey Niew highlighted solid revenue and earnings per share (EPS) performance. Knowles shares gained 13.4% post-earnings, trading at $35.45. TTM Technologies (NASDAQ:TTMI) posted the best overall quarter with revenues up 30.4%, beating estimates by 6.9%, and shares climbing 16% to $159.48. Sector growth prospects include expanding demand in automotive, healthcare, aerospace, and computing. Risks remain from geopolitical tensions and environmental regulations. Analysts remain cautious but optimistic on the sector outlook.

Latest articles

Hesai Up Premarket After Mercedes Lidar Win, Q1 Profit

Hesai Up Premarket After Mercedes Lidar Win, Q1 Profit

19 May 2026
Hesai Group shares rose 2.68% to $22.60 in U.S. premarket trading after reporting a first-quarter profit and confirming it will supply lidar sensors for Mercedes-Benz Level 3 autonomous models. The company shipped 471,723 lidar units, up 140.9% year-on-year, and posted revenue of RMB680.6 million ($98.7 million). Net income reached RMB18.3 million, reversing a loss from a year earlier.
Virax Biolabs Shares Jumping Again Ahead of Nasdaq Open

Virax Biolabs Shares Jumping Again Ahead of Nasdaq Open

19 May 2026
Virax Biolabs shares surged 53.1% Monday to $0.2350 and climbed another 17.1% in early Tuesday premarket trading, hitting $0.2751. The rally followed a paid RedChip TV appearance and a May 15 ownership filing showing Armistice Capital with a 4.99% stake. No new clinical or product updates were posted. Trading volume Monday reached about 765.2 million shares.
Amesite Shares Rise Premarket After NurseMagic Signs Largest Client

Amesite Shares Rise Premarket After NurseMagic Signs Largest Client

19 May 2026
Amesite Inc. shares surged 218% to $2.50 in premarket trading after announcing its largest NurseMagic deployment with a 2,700-patient home-care client. The company disclosed $83,332 in quarterly revenue and a $678,061 net loss, with cash at $740,711 before a $2.2 million April financing. Amesite did not reveal the new contract’s value or customer name. Its latest filing cited “substantial doubt” about ongoing operations.

Popular

Sunshine Biopharma Shares Volatile After $6M Deal, 50-Cent Mark in Focus

Sunshine Biopharma Shares Volatile After $6M Deal, 50-Cent Mark in Focus

19 May 2026
Sunshine Biopharma shares surged as much as 516% before settling up 78% at $0.51 in heavy after-hours Nasdaq trading Monday, following a $6 million public offering priced at $0.50 per unit. More than 436 million shares changed hands, far exceeding the company’s 5 million shares outstanding. The deal includes 12 million units with warrants, raising dilution concerns. Closing is expected around May 19.
Renesas stock price: Wolfspeed stake update lands days before Feb. 5 earnings
Previous Story

Renesas stock price: Wolfspeed stake update lands days before Feb. 5 earnings

Saks Off 5th liquidation sales begin as Saks Global moves to close 57 stores
Next Story

Saks Off 5th liquidation sales begin as Saks Global moves to close 57 stores

Go toTop